For COVID-19 Convalescent Plasma Program Requirements Click Here!
News & Views
Newsletters
Donate
Contact
Search
Close
News & Views
Newsletters
Donate
Contact
Search
Close
About
About Us
Mission, Vision, Core Values
Centers of Excellence
Research Operations
Office of Human Research Protection Program
Office of Clinical Research Coordination
Office of Grants & Contract Management
DHR Research Academy
Research Partnerships & Affiliations
Partnerships & Affiliations
Partner With Us
Sponsors
Core Facilities
For Research Patients
General Information
Clinical Trials
Para Pacientes
Información General
Ensayos Clínicos
For Investigators
For Industry Sponsors
Knowledge Center
Become A Research Patient
Menu
About
About Us
Mission, Vision, Core Values
Centers of Excellence
Research Operations
Office of Human Research Protection Program
Office of Clinical Research Coordination
Office of Grants & Contract Management
DHR Research Academy
Research Partnerships & Affiliations
Partnerships & Affiliations
Partner With Us
Sponsors
Core Facilities
For Research Patients
General Information
Clinical Trials
Para Pacientes
Información General
Ensayos Clínicos
For Investigators
For Industry Sponsors
Knowledge Center
Become A Research Patient
Menu
About
About Us
Mission, Vision, Core Values
Centers of Excellence
Research Operations
Office of Human Research Protection Program
Office of Clinical Research Coordination
Office of Grants & Contract Management
DHR Research Academy
Research Partnerships & Affiliations
Partnerships & Affiliations
Partner With Us
Sponsors
Core Facilities
For Research Patients
General Information
Clinical Trials
Para Pacientes
Información General
Ensayos Clínicos
For Investigators
For Industry Sponsors
Knowledge Center
Become A Research Patient
Donate
5323 S. McColl Rd., Edinburg, TX 78539
dhrresearch@dhr-rgv.com
(956) 362-2390
Trial Category: Cardiology
Results
The Effect of Routine Pacing on Postoperative Atrial Fibrillation in Hispanic Patients Following Coronary Artery Bypass Grafting Procedures
View Details →
Appropriate use of electrocardiographic monitoring in hospitalized patients under the UTRGV Internal Medicine Residency Program.
View Details →
Phase 3 vascular outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (PAD) (Acronym: VOYAGER PAD (Protocol BAY 59-7939/17454)
View Details →
ORION-10 A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
View Details →
ORION-8 A long term extension trial of the Phase III lipid-lowering trials to assess the effect of long term dosing of inclisiran given as subcutaneous injections in subjects with high cardiovascular risk and elevated LDL-C
View Details →
